Eagle Pharmaceuticals, Inc. - Payout Ratio History
Payout ratio history for stock EGRX (Eagle Pharmaceuticals, Inc.).
| Date | Payout ratio |
|---|---|
| December 2020 | 338.34% |
| November 2020 | -375.76% |
| October 2020 | -375.76% |
| September 2020 | -375.76% |
| August 2020 | 701.75% |
| July 2020 | 701.75% |
| June 2020 | 701.75% |
| May 2020 | 120.26% |
| April 2020 | 59.33% |
| March 2020 | 59.33% |
| February 2020 | 59.33% |
| January 2020 | 59.33% |
| December 2019 | 59.33% |
| November 2019 | 59.33% |
| October 2019 | 59.33% |
| September 2019 | 59.33% |
| August 2019 | 59.33% |
| July 2019 | 59.33% |
| June 2019 | 59.33% |
| May 2019 | 59.33% |
| April 2019 | 59.33% |
| March 2019 | 37.92% |
| February 2019 | 37.92% |
| December 2018 | 37.92% |
EGRX
Price: $4.89
52 week price:
Payout Ratio Range:
Earnings Per Share: 0.85 USD
P/E Ratio: 6.88
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 130600
Ebitda: 25.9 millionMarket Capitalization: 63.4 million